Clinical Trials Logo

Hand Dermatitis clinical trials

View clinical trials related to Hand Dermatitis.

Filter by:
  • None
  • Page 1

NCT ID: NCT04375410 Completed - Covid19 Clinical Trials

Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic

Start date: April 22, 2020
Phase:
Study type: Observational

During the COVID-19 pandemic after reopening of the country, school, kindergarten and daycare, children have been obligated to do frequent handwash. The study group wished to investigate whether this has had implications on symptoms of dry, red, itchy or sore hands and hand eczema. The investigation was performed within the first and second week after reopening by questionnaires distributed to parents electronically via schools, kindergartens and daycare facilities electronic platforms.

NCT ID: NCT03703895 Completed - Hand Dermatitis Clinical Trials

A Study for a Topical Medication Versus Placebo in Patients With Hand Dermatitis

AFX5931
Start date: September 18, 2018
Phase: Phase 4
Study type: Interventional

This is a double-blind, pilot study with 20 subjects to determine the tolerability and efficacy of topical AFX 5931 in the treatment of mild to moderate hand dermatitis. Subjects are screened up to 30 days before the baseline visit. Subjects who meet the eligibility criteria may qualify for the study. Subjects will be randomized in a 3:1 ratio to receive either the active or vehicle medication. 15 subjects will receive the active, therapeutic product and 5 subjects will receive the inactive, vehicle product.

NCT ID: NCT01950494 Completed - Hand Dermatitis Clinical Trials

FiteBac Hand Sanitizer in the Management of Hand Dermatitis in Adults

FiteBac
Start date: September 2013
Phase: N/A
Study type: Interventional

Hand dermatitis, (a rash, or eczema, on the hands) is a common skin condition that affects approximately 10% of the population. It can be caused by a wide variety of things, such as allergens or irritants. For some, it can be painful and disfiguring. In moderate to severe cases, hand dermatitis can interfere greatly in the quality of life of the affected person, interfering with work and social functions. This can have a negative psychological effect as well. FiteBac Skin Care Gel is a new over-the-counter hand sanitizer that has been used for hospital and dental hand infection control. This product contains a germicide, to prevent infection. It also contains a silicone polymer. This makes the hand gel more durable, causing it to remain on the skin longer. Despite this durability, the hand gel still allows the skin to naturally perspire (sweat). As people in the health-care industry have used this new product with the goal of reducing hand infections, it has been noted that FiteBac Skin Care Gel also seems to have reduced hand dermatitis and improved personal skin condition. The purpose of this study is to scientifically measure skin improvement in a population of study subjects with hand dermatitis.